Innovation Pharmaceuticals Inc (IPIX)

[Qoheleth]

I previously asked re: a buyout and received a helpful answer from Pete. Upon further consideration (and I understand that we shareholders have nothing to do with this), wouldn't it be more lucrative for us in the long-term were CTIX to enter into licensing agreements which allowed Kevetrin to be used in various applications while we retained ownership of the stock and thus obtain a long-term income revenue? Obviously, I'm long. Is my thinking on this skewed?